Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung CancerScott Gettinger, Julie R. Brahmer, Leora Horn et al.|Journal of Clinical Oncology|2015Cited by 1.2k
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung CancerLecia V. Sequist, D. Ross Camidge, Shannon Matheny et al.|New England Journal of Medicine|2015Cited by 664
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alterationAlexander Drilon, Paul K. Paik, Jeffrey W. Clark et al.|Nature Medicine|2020Cited by 393
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung CancerAnna F. Farago, Benjamin J. Drapkin, Beow Y. Yeap et al.|Cancer Discovery|2019Cited by 238
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived XenograftsBenjamin J. Drapkin, Anna F. Farago, Julie George et al.|Cancer Discovery|2018Cited by 216